Application
 
Applications in Vaccines

High performance virus production can be a challenge for your research and vaccine production requirements. Whether you are using mammalian cell lines or other virus production systems, the need for consistent and high yielding cultures is a top priority.

Many cell lines used for live virus production and vaccines, such as Vero and HEK 293, can be difficult to culture. This makes it difficult to consistently produce a high live virus titre. The challenges continually addressed include:

  • Poor host cell growth
  • Increased host cell apoptosis
  • Poor cell adherence to microcarriers
  • Low viral yield and inadequate live virus production
  • Lack of performance from chemically-defined media
  • Inconsistent cell performance and viral yield between lots

InVitria's scientists have developed new animal-free media additives that perform well when replacing animal components or as performance enhancing additives for chemically-defined media in a viral vaccine production system. Cellastim, InVitria’s recombinant human albumin, consistently improves cell line growth and live virus titre while maintaining a chemically-defined media.

The superior cell culture media supplements offered by InVitria:

  • Maximize growth of many mammalian cell lines, including Vero and HEK 293
  • Increase host cell adherence to microcarriers
  • Optimize live virus production and live virus titre
  • Increase cell viability and density while stabilizing the virus
  • Are chemically-defined and well-characterized supplements
  • Ensure lot-to-lot consistency
  • Are free of animal or blood derivatives, such as bovine serum albumin (BSA)
  • Regulatory-friendly
 
  • Blog: The Cell Culture Dish

    Cell Culture Media supplement Blog Exciting Treatment Possibilities with Stem Cells; What is the Best Cell Culture Method?

    Researchers at Memorial Hermann-Texas Medical Center are working towards using umbilical cord blood stem cell transplants to limit or reverse hearing loss in infants. They have been able to confirm that stem cells inserted into the ears of mice helped rebuild their inner ear structure and they are betting that the same can be done with human infants. Another study conducted by the University of Texas, Health Science Center at Houston (UT Health) and published in the journal Neurosurgery examined the use of stem cells to treat traumatic brain injury... Read More

  • Latest News

    Invitria Cell Culture Media News InVitria Successfully Completes National Institutes of Health Grant for Animal-Free Media Supplements

    November 30, 2011 – The National Institutes of Health (NIH) awarded InVitria a $725,000 Phase II, Small Business Innovation Research (SBIR) Grant to broaden the applications for InVitria's recombinant human serum albumin product Cellastim®... read more